United States · Series E startup
5 rounds we have observed, with the 12 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$84Mraised across 5 rounds since 2006, from 5 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Goldman Sachs
Flybridge
Polaris Partners
Aisling Capital
Physic Ventures
Partners Healthcare GroupReported by pevc.dowjones.comSEC filing: $400M sold, first sale Mar 2013
FlybridgePolaris Partners
RA Capital ManagementAisling CapitalPhysic VenturesPartners Healthcare GroupReported by masshightech.comSEC filing: $23M sold, first sale Aug 2011
FlybridgePolaris PartnersRA Capital ManagementPhysic VenturesPartners Healthcare GroupReported by onbiovc.comSEC filing: $15M sold, first sale May 2010
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
FlybridgePolaris PartnersFlagship Pioneering, LLCPhysic VenturesWS InvestmentsArcus VenturesPartners Healthcare GroupCamros CapitalRA Capital ManagementAisling CapitalMissing a round, or an investor who was in one? Tell us.
T2 Biosystems's investors include Flybridge, Polaris Partners, Flagship Pioneering, LLC, Physic Ventures and WS Investments, and 7 more on record.
T2 Biosystems has raised $84M across 5 rounds since 2006. One round did not disclose an amount, so the total is a floor.
T2 Biosystems's most recent round was a Series E of $40M in Mar 2013.
Its most recent round, $40M in Mar 2013, is also its largest on record.
T2 Biosystems's first round on record, in Jan 2006, was backed by Flybridge, Polaris Partners and Flagship Pioneering, LLC.
T2 Biosystems's latest named round is a Series E, in Mar 2013.
T2 Biosystems is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States · 